Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of NAFLD with cardiovascular disease and all-cause mortality: a large-scale prospective cohort study based on UK Biobank
Wen Ma, Wentao Wu, Weixing Wen, et al.
Therapeutic Advances in Chronic Disease (2022) Vol. 13
Open Access | Times Cited: 19

Showing 19 citing articles:

NAFLD: An Emerging Causal Factor for Cardiovascular Disease
Mei Li, Horng‐Dar Wang, Xiao‐Jing Zhang, et al.
Physiology (2023) Vol. 38, Iss. 6, pp. 255-265
Closed Access | Times Cited: 24
Linking Cardiovascular Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Role of Cardiometabolic Drugs in MASLD Treatment
Marios Zisis, Maria Chondrogianni, Θεόδωρος Ανδρουτσάκος, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 324-324
Open Access | Times Cited: 1
Sex differences in mortality and liver‐related events in non‐alcoholic fatty liver disease: A systematic review and meta‐analysis
Huimin Zhou, Haiyan Chen, Hanxiao Lu, et al.
Liver International (2024) Vol. 44, Iss. 7, pp. 1600-1609
Closed Access | Times Cited: 8
Fatty liver index is an independent risk factor for all-cause mortality and major cardiovascular events in type 1 diabetes: an 11-year observational study
Monia Garofolo, Daniela Lucchesi, MASSIMO GIAMBALVO, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Liver fat as risk factor of hepatic and cardiometabolic diseases
Münevver Demir, Stefan R. Bornstein, Christos S. Mantzoros, et al.
Obesity Reviews (2023) Vol. 24, Iss. 10
Open Access | Times Cited: 12
Predicting hepatic steatosis degree in metabolic dysfunction-associated steatotic liver disease using obesity and lipid-related indices
Paniz Forouzesh, Sorayya Kheirouri, Mohammad Alizadeh
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases
Pin‐Nan Cheng, Wen‐Jone Chen, Charles Jia‐Yin Hou, et al.
Clinical and Molecular Hepatology (2023) Vol. 30, Iss. 1, pp. 16-36
Open Access | Times Cited: 10
Myricitrin Alleviates Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease in High Cholesterol Diet-Fed Mice
Young‐Je Kim, Sojeong Park, HwiCheol Kim, et al.
Nutrients (2025) Vol. 17, Iss. 3, pp. 415-415
Open Access
Body Fat Distribution Contributes to Defining the Relationship between Insulin Resistance and Obesity in Human Diseases
María M. Adeva‐Andany, Alberto Domínguez-Montero, Lucía Adeva-Contreras, et al.
Current Diabetes Reviews (2023) Vol. 20, Iss. 5
Closed Access | Times Cited: 9
Sex differences in cardiovascular and all-cause mortality in nonalcoholic fatty liver disease in the US population
Ruirui Ren, Yang Zheng
Nutrition Metabolism and Cardiovascular Diseases (2023) Vol. 33, Iss. 7, pp. 1349-1357
Closed Access | Times Cited: 8
Effects of a High Trans Fatty Acid Diet on Kidney-, Liver-, and Heart-Associated Diseases in a Rabbit Model
Hammad Ismail, Zaryab Mubashar, Hajra Khan, et al.
Metabolites (2024) Vol. 14, Iss. 8, pp. 442-442
Open Access | Times Cited: 2
NAFLD is a predictor of high risk of development and a co-factor in the progression of cardiovascular diseases
Г. В. Шавкута, С. В. Туркина
South Russian Journal of Therapeutic Practice (2024) Vol. 5, Iss. 2, pp. 29-37
Open Access | Times Cited: 1
Non-alcoholic fatty liver disease is associated with coronary flow reserve impairment: A pilot meta-analysis
Hritvik Jain, Neha Pervez, Debankur Dey, et al.
Medicine (2024) Vol. 103, Iss. 36, pp. e39499-e39499
Open Access | Times Cited: 1
Mapping the global research landscape on nonalcoholic fatty liver disease and insulin resistance: A visualization and bibliometric study
Sa’ed H. Zyoud, Omar E Hegazi, Samer O Alalalmeh, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 6, pp. 951-965
Open Access | Times Cited: 1
Consensus Statements from the Diabetologists & Endocrinologists Alliance for the Management of People with Hypertension and Type 2 Diabetes Mellitus
Peter Chun-Yip Tong, Susanna Chi-Pun Chan, Wing-Bun Chan, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3403-3403
Open Access | Times Cited: 2
Adipose Tissue Dysfunction and Energy Balance Paradigms in People Living With HIV
Claudia E. Ramirez, Neeti Agarwal, Aaron R. Cox, et al.
Endocrine Reviews (2023) Vol. 45, Iss. 2, pp. 190-209
Open Access | Times Cited: 2
Influence of nonalcoholic fatty liver disease on inflammatory bowel disease hospitalizations in the United States
Aakriti Soni
Annals of Gastroenterology (2023)
Open Access | Times Cited: 2
FIB-4 Index and Neutrophil-to-Lymphocyte-Ratio as Death Predictor in Coronary Artery Disease Patients
Melania Gaggini, Fabrizio Minichilli, Francesca Gorini, et al.
Biomedicines (2022) Vol. 11, Iss. 1, pp. 76-76
Open Access | Times Cited: 3
Fatty liver index as an independent predictor of all-cause and disease-specific mortality
Ruixin Zhang, Shuhao Ren, Hongfei Mi, et al.
European Journal of Gastroenterology & Hepatology (2024) Vol. 36, Iss. 12, pp. 1453-1463
Closed Access
Page 1

Scroll to top